Newtyn Management, LLC - Q2 2023 holdings

$423 Million is the total value of Newtyn Management, LLC's 46 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 50.0% .

 Value Shares↓ Weighting
IAC SellIAC INC$56,520,000
+20.9%
900,000
-0.6%
13.35%
+45.4%
CNNE BuyCANNAE HLDGS INC$40,635,499
+61.1%
2,010,663
+60.9%
9.60%
+93.6%
GIII BuyG III APPAREL GROUP LTD$31,707,860
+32.4%
1,645,452
+6.9%
7.49%
+59.2%
PAR SellPAR TECHNOLOGY CORP$29,637,000
-7.9%
900,000
-5.0%
7.00%
+10.8%
 ARDAGH METAL PACKAGING S A$26,320,000
-7.8%
7,000,0000.0%6.22%
+10.8%
MACK  MERRIMACK PHARMACEUTICALS IN$23,046,436
+0.1%
1,873,6940.0%5.44%
+20.3%
SPB  SPECTRUM BRANDS HLDGS INC NE$19,507,583
+17.9%
249,9370.0%4.61%
+41.7%
VTOL BuyBRISTOW GROUP INC$19,371,777
+54.6%
674,270
+20.5%
4.58%
+85.9%
CIO BuyCITY OFFICE REIT INC$17,042,646
+60.0%
3,059,721
+98.2%
4.03%
+92.3%
TBPH BuyTHERAVANCE BIOPHARMA INC$16,978,720
+2.2%
1,640,456
+7.1%
4.01%
+22.9%
BuyORION OFFICE REIT INC$15,136,900
+3.1%
2,290,000
+4.5%
3.58%
+23.9%
MBI BuyMBIA INC$12,052,800
+21.4%
1,395,000
+30.1%
2.85%
+45.9%
GTX NewGARRETT MOTION INC$11,219,8681,482,149
+100.0%
2.65%
GLPG BuyGALAPAGOS NVspon adr$10,978,200
+5.9%
270,000
+0.6%
2.59%
+27.3%
PHAT BuyPHATHOM PHARMACEUTICALS INC$9,789,839
+101.0%
683,648
+0.2%
2.31%
+141.7%
Sell2SEVENTY BIO INC$7,465,969
-51.4%
737,744
-51.0%
1.76%
-41.5%
NODK BuyNI HLDGS INC$6,831,000
+21.9%
460,000
+6.8%
1.61%
+46.6%
KOD BuyKODIAK SCIENCES INC$6,828,951
+23.4%
989,703
+10.9%
1.61%
+48.3%
TLYS BuyTILLYS INCcl a$5,608,000
+1.1%
800,000
+11.2%
1.32%
+21.7%
 FORUM ENERGY TECHNOLOGIES INnote 9.000% 8/0$5,429,033
-0.6%
5,483,8720.0%1.28%
+19.5%
DXLG BuyDESTINATION XL GROUP INC$5,390,000
-8.1%
1,100,000
+3.3%
1.27%
+10.4%
SellSTAR HLDGS$4,760,004
-15.6%
324,472
-0.0%
1.12%
+1.4%
PCG  PG&E CORP$4,646,955
+6.9%
268,9210.0%1.10%
+28.6%
FET BuyFORUM ENERGY TECHNOLOGIES IN$4,606,200
+1.7%
180,000
+1.1%
1.09%
+22.2%
 ALGOMA STL GROUP INC$4,195,383
-12.1%
590,8990.0%0.99%
+5.7%
ETNB  89BIO INC$3,790,000
+24.4%
200,0000.0%0.90%
+49.4%
CYT BuyCYTEIR THERAPEUTICS INC$3,530,927
+103.6%
1,358,049
+42.5%
0.83%
+144.6%
PFSW BuyPFSWEB INC$3,373,755
+11.1%
746,406
+4.3%
0.80%
+33.7%
AMPY SellAMPLIFY ENERGY CORP NEW$2,662,059
-65.9%
393,214
-65.4%
0.63%
-59.0%
SNSE BuySENSEI BIOTHERAPEUTICS INC$2,083,054
-9.9%
1,827,240
+18.6%
0.49%
+8.4%
WVE SellWAVE LIFE SCIENCES LTD$1,820,000
-18.2%
500,000
-2.7%
0.43%
-1.6%
PRTK NewPARATEK PHARMACEUTICALS INC$1,689,046764,274
+100.0%
0.40%
ADVM SellADVERUM BIOTECHNOLOGIES INC$1,590,000
+45.0%
1,000,000
-34.6%
0.38%
+74.9%
OLMA SellOLEMA PHARMACEUTICALS INC$1,580,250
+21.4%
175,000
-53.3%
0.37%
+45.7%
BOLT SellBOLT BIOTHERAPEUTICS INC$1,280,000
-17.4%
1,000,000
-10.3%
0.30%
-1.0%
BDTX SellBLACK DIAMOND THERAPEUTICS I$1,010,000
+74.3%
200,000
-34.8%
0.24%
+109.6%
ALGS SellALIGOS THERAPEUTICS INC$873,900
-2.1%
900,000
-11.9%
0.21%
+17.7%
DBTX SellDECIBEL THERAPEUTICS INC$770,000
+0.5%
200,000
-21.2%
0.18%
+20.5%
ABIO SellARCA BIOPHARMA INC$635,796
-38.5%
313,200
-39.7%
0.15%
-26.1%
AVIR NewATEA PHARMACEUTICALS INC$333,59789,197
+100.0%
0.08%
LW SellLAMB WESTON HLDGS INC$247,947
-98.3%
2,157
-98.5%
0.06%
-97.9%
SellGLOBAL BUSINESS TRAVEL GROUP$223,573
-96.8%
30,923
-97.1%
0.05%
-96.2%
BRLIR  BRILLIANT ACQUISITION CORPright 99/99/9999$63,809
-3.1%
457,4090.0%0.02%
+15.4%
 LEAFLY HOLDINGS INC*w exp 02/04/202$19,230
-13.4%
634,6400.0%0.01%
+25.0%
 ARISZ ACQUISITION CORPright 99/99/9999$22,200
+2.2%
250,0000.0%0.01%
+25.0%
VHAQRT  VIVEON HEALTH ACQUISITION COright 12/31/2025$14,325
+14.6%
250,0000.0%0.00%
+50.0%
ExitINVIVYD INC$0-12,937
-100.0%
-0.00%
ExitIO BIOTECH INC$0-49,346
-100.0%
-0.02%
NUVB ExitNUVATION BIO INC$0-215,000
-100.0%
-0.07%
CLBK ExitCOLUMBIA FINL INC$0-19,600
-100.0%
-0.07%
CIX ExitCOMPX INTL INCcl a$0-20,737
-100.0%
-0.07%
FBRX ExitFORTE BIOSCIENCES INC$0-410,740
-100.0%
-0.08%
ExitTSCAN THERAPEUTICS INC$0-236,800
-100.0%
-0.10%
ExitPONCE FINANCIAL GROUP INC$0-70,351
-100.0%
-0.11%
ExitGENEDX HOLDINGS CORP$0-1,705,000
-100.0%
-0.12%
PASG ExitPASSAGE BIO INC$0-665,221
-100.0%
-0.12%
IOVA ExitIOVANCE BIOTHERAPEUTICS INC$0-105,000
-100.0%
-0.13%
CTMX ExitCYTOMX THERAPEUTICS INC$0-425,000
-100.0%
-0.13%
ORIC ExitORIC PHARMACEUTICALS INC$0-133,999
-100.0%
-0.15%
FFWM ExitFIRST FNDTN INC$0-105,000
-100.0%
-0.15%
LTCH ExitLATCH INC$0-1,200,000
-100.0%
-0.18%
ALEC ExitALECTOR INC$0-155,000
-100.0%
-0.19%
AMR ExitALPHA METALLURGICAL RESOUR I$0-6,319
-100.0%
-0.19%
TCRR ExitTCR2 THERAPEUTICS INC$0-1,015,920
-100.0%
-0.30%
ATAI ExitATAI LIFE SCIENCES NV$0-960,000
-100.0%
-0.34%
BKU ExitBANKUNITED INC$0-80,000
-100.0%
-0.36%
DNMR ExitDANIMER SCIENTIFIC INC$0-535,000
-100.0%
-0.36%
CMRX ExitCHIMERIX INC$0-1,516,000
-100.0%
-0.38%
COLL ExitCOLLEGIUM PHARMACEUTICAL INC$0-100,000
-100.0%
-0.47%
VBTX ExitVERITEX HLDGS INC$0-135,000
-100.0%
-0.48%
NHF ExitNEXPOINT DIVERSIFIED REL ET$0-287,029
-100.0%
-0.58%
FLWS Exit1 800 FLOWERS COM INCcl a$0-319,466
-100.0%
-0.72%
OCFC ExitOCEANFIRST FINL CORP$0-200,000
-100.0%
-0.73%
WBS ExitWEBSTER FINL CORP$0-105,000
-100.0%
-0.81%
CMA ExitCOMERICA INC$0-105,000
-100.0%
-0.90%
SFIX ExitSTITCH FIX INC$0-960,000
-100.0%
-0.96%
EBC ExitEASTERN BANKSHARES INC$0-425,000
-100.0%
-1.05%
QTWO ExitQ2 HLDGS INC$0-300,000
-100.0%
-1.45%
ExitSAFEHOLD INC$0-339,319
-100.0%
-1.96%
BCOR ExitAVANTAX INC$0-400,000
-100.0%
-2.07%
CUBI ExitCUSTOMERS BANCORP INC$0-625,000
-100.0%
-2.27%
ADNT ExitADIENT PLC$0-345,000
-100.0%
-2.78%
GTXAP ExitGARRETT MOTION INCpfd conv ser a$0-1,693,092
-100.0%
-2.96%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPIRIT AEROSYSTEMS HLDGS INC33Q2 202124.0%
NI HLDGS INC27Q3 20232.9%
ADIENT PLC26Q1 202317.3%
MERRIMACK PHARMACEUTICALS IN25Q3 20235.7%
PG&E CORP24Q3 202319.2%
SPECTRUM BRANDS HLDGS INC NE21Q3 20236.7%
RAFAEL HLDGS INC18Q2 20227.4%
CUSTOMERS BANCORP INC18Q1 20233.7%
BRISTOW GROUP INC14Q3 20234.8%
APPLIED OPTOELECTRONICS INC14Q3 20212.2%

View Newtyn Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Newtyn Management, LLC Q2 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
PFSWEB INCFebruary 14, 20231,206,5025.3%
Garrett Motion Inc.February 14, 20221,571,4512.4%
Flexion Therapeutics IncNovember 24, 20214,400,0008.7%
FLOTEK INDUSTRIES INC/CN/February 16, 20212,789,0593.8%
Forward Pharma A/SSold outFebruary 16, 202100.0%
Pfenex Inc.October 02, 2020650,0001.9%
CymaBay Therapeutics, Inc.Sold outFebruary 14, 202000.0%
Recro Pharma, Inc.Sold outFebruary 14, 202000.0%
Stable Road Acquisition Corp.February 14, 2020700,0003.9%
CSW INDUSTRIALS, INC.February 14, 2017330,0002.1%

View Newtyn Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-03-08
SC 13D/A2024-03-07
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
SC 13D/A2024-02-13
SC 13D/A2024-01-25

View Newtyn Management, LLC's complete filings history.

Compare quarters

Export Newtyn Management, LLC's holdings